====== ID Biomedical ======

{{ :pharmaceutical_companies:miaoum46fyrdxxzj8tkm_copy.png?200|}}

**ID Biomedical** is a Canadian subsidiary of [[GlaxoSmithKline]] based in Sainte-Foy, [[:canada:Quebec]].((Health Canada. (2014, July 21). //Summary Report - ID Biomedical Corporate of Quebec (GSK).// Government of Canada. https://web.archive.org/web/20220428153830/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/summary-report-biomedical-corporate-quebec.html))

The company was dedicated to the manufacturing and development of innovative [[:vaccines|vaccine products]], including [[:influenza vaccines]].((//FOI Request - HTH-2015-51828.// (2016, February 12). Government of British Columbia. https://web.archive.org/web/20220428045844/http://docs.openinfo.gov.bc.ca/Response_Package_HTH-2015-51828.pdf))

===== History =====

Formerly based in [[:Canada:british_columbia:Vancouver]], [[:canada:British Columbia]], the company was bought by GSK in 2005 for $1.7 billion.((//GlaxoSmithKline buys Vancouver’s ID Biomedical for $1.7 billion.// (2005, September 7). CBC News. https://www.cbc.ca/news/business/glaxosmithkline-buys-vancouver-s-id-biomedical-for-1-7-billion-1.534195))